药械指南

订阅

MedSci主页 / 所有栏目 / 药械指南

关于药品注册申请实施电子申报承诺书（征求意见稿）

2022-11-04 国家药品监督管理局（NMPA）

为落实“放管服”改革要求，进一步优化营商环境，减轻企业负担，推进药品注册申请电子申报工作，国家药监局组织起草了相关征求意见稿文件。

中文标题：

关于药品注册申请实施电子申报承诺书（征求意见稿）

发布机构：

国家药品监督管理局（NMPA）

发布日期：

2022-11-04

简要介绍：

为落实“放管服”改革要求，进一步优化营商环境，减轻企业负担，推进药品注册申请电子申报工作，国家药监局组织起草了《关于药品注册申请实施电子申报的公告（征求意见稿）》以及《关于药品注册申请电子申报有关要求的通知（征求意见稿）》《申报资料电子光盘技术要求（征求意见稿）》《药品注册申请电子文档结构（征求意见稿）》和《承诺书（征求意见稿）》（见附件），现向社会公开征求意见。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=关于药品注册申请实施电子申报承诺书（征求意见稿）.doc)] GetToolGuiderByIdResponse(projectId=1, id=f8a371c002e822ef, title=关于药品注册申请实施电子申报承诺书（征求意见稿）, enTitle=, guiderFrom=, authorId=0, author=, summary=为落实“放管服”改革要求，进一步优化营商环境，减轻企业负担，推进药品注册申请电子申报工作，国家药监局组织起草了相关征求意见稿文件。, cover=, journalId=0, articlesId=null, associationId=1683, associationName=国家药品监督管理局（NMPA）, associationIntro=国家药品监督管理局（NMPA）, copyright=0, guiderPublishedTime=Fri Nov 04 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p>为落实&ldquo;放管服&rdquo;改革要求，进一步优化营商环境，减轻企业负担，推进药品注册申请电子申报工作，国家药监局组织起草了《关于药品注册申请实施电子申报的公告（征求意见稿）》以及《关于药品注册申请电子申报有关要求的通知（征求意见稿）》《申报资料电子光盘技术要求（征求意见稿）》《药品注册申请电子文档结构（征求意见稿）》和《承诺书（征求意见稿）》（见附件），现向社会公开征求意见。</p> <p>&nbsp;</p>, tagList=[], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=33, categoryName=政策人文, tenant=100), CategoryDto(categoryId=34, categoryName=全科医学, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=政策, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1653, appHits=12, showAppHits=0, pcHits=129, showPcHits=1641, likes=0, shares=4, comments=2, approvalStatus=1, publishedTime=Sat Nov 19 16:35:00 CST 2022, publishedTimeString=2022-11-04, pcVisible=1, appVisible=1, editorId=0, editor=QIAN LIN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=7, createdBy=null, createdName=QIAN LIN, createdTime=Mon Nov 07 16:29:10 CST 2022, updatedBy=6459136, updatedName=玉在山, updatedTime=Sat Jan 06 13:37:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=关于药品注册申请实施电子申报承诺书（征求意见稿）.doc)])
关于药品注册申请实施电子申报承诺书（征求意见稿）.doc
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2101519, encodeId=a0ce210151903, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Sat Nov 19 18:00:21 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101518, encodeId=56392101518c5, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Sat Nov 19 18:00:17 CST 2022, time=2022-11-19, status=1, ipAttribution=)]
    2022-11-19 ms3000002106324246

    1

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2101519, encodeId=a0ce210151903, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Sat Nov 19 18:00:21 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101518, encodeId=56392101518c5, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Sat Nov 19 18:00:17 CST 2022, time=2022-11-19, status=1, ipAttribution=)]
    2022-11-19 ms3000002106324246

    #DIA#

    0